Sun Yat-sen University: Lymphoma, Non-Hodgkin trials

The registry lists 10 Lymphoma, Non-Hodgkin studies with Sun Yat-sen University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3ANot yet recruitingNCT06961500Phase 2
• High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)Not yet recruitingNCT06646211Phase 2
• A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBLRecruitingNCT03971318
• A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCLRecruitingNCT03971305
• Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCLRecruitingNCT03958916
• A Retrospective Cohort Study: Influence of MTHFR C677T and A1298C Polymorphisms on the Survival of Pediatric Patients With Non-Hodgkin's LymphomaCompletedNCT04469543
• A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic LymphomaStatus unknownNCT04320992
• A Retrospective Cohort Study: The Influence of MTHFR C677T and A1298C on the High-dose Methotrexate-Related Toxicities in Pediatric Patients With Non-Hodgkin LymphomaCompletedNCT04283955
• Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHLStatus unknownNCT03245905Phase 2
• Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's LymphomaCompletedNCT01761500Phase 2